Efficacy of Interferon β Combined With Cyclosporine Induction and Intensified Therapy for Retreatment of Chronic Hepatitis C

Transplantation Proceedings

Volumn 41, Issue 1, 2009, Pages 246-249

  Inoue, K ^a   Watanabe, T ^a   Yamada, M ^a   Yoshikumi, H ^a   Ogawa, O ^a   Yoshiba, M ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYCLOSPORIN A; INTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GENOTYPE; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERTENSION; INSOMNIA; KIDNEY DYSFUNCTION; LIVER TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RETINOPATHY; SIDE EFFECT; THROMBOCYTOPENIA; THYROID DISEASE; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; TREMOR; VISUAL IMPAIRMENT;

ADULT; AGED; ANTIVIRAL AGENTS; CYCLOSPORINE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON ALFA-2A; INTERFERON-BETA; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RIBAVIRIN; SAFETY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 60649086770     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.10.056     Document Type: Article

References (19)

1. Berenguer M., Prieto M., Rayon J.M., et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 32 (2000) 852
2. Berenguer M., Ferrell L., Watson J., et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 32 (2000) 673
3. Forman L.M., Lewis J.D., Berlin J.A., et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 122 (2002) 889
4. Burra P., Targhetta S., Pevere S., et al. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience. Transplant Proc 38 (2006) 1127
5. Shergill A.K., Khalili M., Straley S., et al. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant 5 (2005) 118
6. Ahmad J., Dodson S.F., Demetris A.J., et al. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl 7 (2001) 863
7. Lavezzo B., Franchello A., Smedile A., et al. Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin. J Hepatol 37 (2002) 247
8. Samuel D., Bizollon T., Feray C., et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 124 (2003) 642
9. Sheiner P.A., Boros P., Klion F.M., et al. The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 28 (1998) 831
10. Inoue K., Sekiyama K., Yamada M., et al. Combined interferon alpha 2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial. J Gastroenterol 38 (2003) 567
11. Inoue K., Umehara T., Ruegg U.T., et al. Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo. Hepatology 45 (2007) 921
12. Guitard J., Sandres-Saune K., Kamar N., et al. Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study. Transplant Proc 39 (2007) 2603
13. Kamar N., Selves J., Sandres-Saune K., et al. Does cyclosporine have a beneficial effect on the course of chronic hepatitis C infection after renal transplantation?. Transplant Proc 38 (2006) 1329
14. Rayhill S.C., Barbeito R., Katz D., et al. A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C. Transplant Proc 38 (2006) 3625
15. Oton E., Barcena R., Castillo M., et al. Hepatitis C virus recurrence after liver transplantation: influence of immunosuppressive regimens on viral load and liver histology. Transplant Proc 38 (2006) 2499
16. Ichikawa Y., Kishikawa H., Nishimura K., et al. Retrospective study of the effects of cyclosporine in comparison with azathioprine on renal transplant recipients infected with hepatitis C virus. Transplant Proc 38 (2006) 3451
17. Villamil F., Levy G., Grazi G.L., et al. Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine. Transplant Proc 38 (2006) 2964
18. Cervelli C., Fontecchio G., Fioroni M.A., et al. Interferon-alpha therapy and anti-human leukocyte antigen antibodies in hepatitis C virus-positive patient: case report. Transplant Proc 39 (2007) 2040
19. Foy E., Li K., Wang C., et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300 (2003) 1145